Tocqueville Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Tocqueville Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,225	Closed	-$742K	–	883
2017 Q4	$742K	Buy	+16,225	New	+$809K	0.01%	553
2016 Q4	–	Sell	-18,500	Closed	-$555K	–	876
2016 Q3	$555K	Sell	18,500 -15,700	-46%	-$488K	0.01%	611
2016 Q2	$1.31M	Sell	34,200 -50	-0.1%	-$2.08K	0.02%	475
2016 Q1	$1.3M	Sell	34,250 -43,640	-56%	-$1.52M	0.02%	459
2015 Q4	$3.42M	Sell	77,890 -450	-0.6%	-$22.3K	0.05%	338
2015 Q3	$3.19M	Buy	78,340 +12,195	+18%	+$535K	0.04%	368
2015 Q2	$3.53M	Buy	66,145 +37,845	+134%	+$2.01M	0.04%	373
2015 Q1	$1.72M	Buy	28,300 +20,000	+241%	+$971K	0.02%	498
2014 Q4	$433K	Buy	+8,300	New	+$371K	﹤0.01%	736

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Tocqueville Asset Management's JUNO Position: Q1 2018 in Review

Tocqueville Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,225 shares — an estimated $742K sold.

Tocqueville Asset Management first reported a position in JUNO in Q4 2014 and held it in 9 quarters. The position peaked at $3.53M in Q2 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Tocqueville Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Tocqueville Asset Management sold 16,225 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $742K.
Tocqueville Asset Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
Tocqueville Asset Management's Juno Therapeutics, Inc. position peaked at $3.53M in Q2 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Tocqueville Asset Management's 13F filing for Q1 2018, filed 14 May 2018.